NEW YORK (GenomeWeb) – NanoString Technologies today priced its public offering of 4 million shares of common stock at $12.50 per share.

The firm had announced its intention to offer $50 million worth of stock earlier this week.

NanoString also granted underwriters of the offering a 30-day option to purchase up to an additional 600,000 shares of common stock at the public offering price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.